Autolus Therapeutics Plc (AUTL)
1.65
+0.04
(+2.48%)
USD |
NASDAQ |
Apr 17, 13:31
Autolus Therapeutics Cash from Operations (Quarterly) : -67.21M for Dec. 31, 2025
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Mereo BioPharma Group Plc | -7.670M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -1.253M |
| Bicycle Therapeutics Plc | -19.10M |
| DBV Technologies SA | -35.19M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 86.65M |
| Cash from Financing (Quarterly) | -1.798M |
| Free Cash Flow | -311.43M |
| Free Cash Flow Per Share (Quarterly) | -0.2491 |
| Free Cash Flow to Equity (Quarterly) | -92.69M |
| Free Cash Flow to Firm (Quarterly) | -43.78M |
| Free Cash Flow Yield | -70.92% |